MedPage Today on MSN
Single-Tablet Combo Matched Complex Regimens in Older HIV Patients
"Time has stood still" for many who've been on complex regimens for decades ...
HIV patients on a single-tablet daily regimen had better outcomes than patients taking multiple pills per day, a new study shows. HIV patients on a single-tablet daily regimen had better treatment ...
Results from ARTISTRY trials will be submitted to regulatory agencies for review. Topline results were announced from a phase 3 trial evaluating bictegravir 75mg/lenacapavir 50mg (BIC/LEN), an ...
ARTISTRY-1 trial showed BIC/LEN is effective in maintaining viral suppression in HIV patients previously on complex ART regimens. BIC/LEN offers a single-tablet alternative for patients with drug-drug ...
– Phase 3 Results from ARTISTRY-1 and 2 Trials will Form the Basis of Regulatory Submissions – FOSTER CITY, Calif., November 13, 2025--(BUSINESS WIRE)--Gilead Sciences, Inc. (NASDAQ: GILD) today ...
HIV patients on a single-tablet daily regimen had better treatment retention and viral suppression than patients taking multiple pills, in a study by a Michael E. DeBakey Veterans Affairs Medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results